Tony Chen

Tony Chen is the CEO of PrimeVax Immuno-Oncology, a cancer biotech start-up. Tony’s experience spans management and strategy consulting, clinical research services, and the US Department of Health and Human Services (HHS). Prior to leading PrimeVax, Tony helped launch drugs in immuno-oncology and rare diseases. Prior to this role, Tony helped implement the Affordable Care Act at HHS.